backfround 2

About the company

H&AD

H&AD — Herbal & Antioxidant Derivatives — is a renowned Italian company that develops and markets dietary supplements and nutraceuticals in more than 20 countries throughout Europe and Asia, as well as Australia and the USA.

H&AD’s mission is to provide superior standards of quality products that are supported by credible research and evidence-based studies of their efficacy for consumers. Our focus on health care and nutraceuticals derives from centuries of traditional experience and consumption of Mediterranean fruits and natural remedies.

Along with pre-clinical and clinical studies proving our products’ effectiveness, we adopted the longstanding principles of the Mediterranean Diet, which is characterized by consuming an abundance of vegetables and citrus.

Within this context, we re-evaluated the use of Bergamot, which has been used for centuries in traditional medicine to improve circulatory and metabolic wellness, and to support cardiovascular function.

Bergamot is a unique, hardy and nutrition-packed citrus with multiple uses, from fragrance to nutraceuticals. Bergamot is distinguished from other varieties of citrus for its high content of polyphenols, which are known for their potent antioxidant abilities.

Today, H&AD is considered one of the top-ranking companies in Bergamot derivatives and natural products. H&AD is the owner of several patents concerning both the extraction procedures and the therapeutic efficiency of its products.

 

H&AD

Millenstones

2008

H&AD was founded to become the global expert in bergamot derivatives.

2009

Patent #102007901561180 was awarded for Bergamot Juice IT

2010

Another Bergamot patent was awarded (WO/2010/055490)

phytocomplex from Bergamot fruit process of manufacture and use as dietary supplement and the pharmaceutical field.

2015

H&AD acquires new headquarters in Calabria, Italy.

2018

Patent #WO/2018/189672 awarded for Bergacyn extract

extracts of Cynara cardunculus and Citrus Aurantium Bergamia, combinations thereof, and formulations containing them.

2019

BPF registered at FSSAI (India)

2020

Patent on Ferula extract WO/2020/144588

Compositions for treatment of the menopause, osteopenia and osteoporos, and menopause/related metabolic and vascular disorders

2021

New shareholders: Cilione Srl (Calabria,IT) and HP Ingredients Corp (Florida, US)

H&AD

Millenstones

2008

Foundation of the company.

2009

Patent on Bergamot Juice IT 102007901561180

Uso di succo di Bergamotto e, o i suoi derivati come agenti ad attività antidislipidemica ed antiaterogena

2010

Patent Bergamot extrat WO/2010/055490

Phytocomplex from Bergamot fruit process of manufacture and use as dietary supplement and the pharmaceutical field

2015

Acquisition of the new headquarters in Calabria

2018

Patent on Bergacyn extract WO/2018/189672

Extracts of Cynara Cardunculus and Citrus Aurantium Bergamia, combinations thereof, and formulations containing them

2019

Registration of BPF at the FSSAI (INDIA)

2020

Patent on Ferula extract WO/2020/144588

Compositions for treatment of the menopause, osteopenia and osteoporos, and menopause/related metabolic and vascular disorders

2021

New shareholders: Cilione Srl (Calabria,IT) and HP Ingredients Corp (Florida, US)

H&AD

Certifications

H&AD

Patents